Q1 2025 Management View CEO Celeste Mastin highlighted positive organic sales growth in Q1 2025, with a 1.9% year-over-year increase driven primarily by improving volume trends and moderate pricing ...
CEO Anderson expressed confidence in achieving double-digit adjusted EBITDA growth in 2025. CFO Sabrina Simmons outlined three financial priorities: gross margin expansion, SG&A leverage ...
“Nouryon’s 2024 full-year financial performance underscores the strength of our specialty portfolio, driving significant adjusted EBITDA growth and margin expansion," said Charlie ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results